Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

被引:4
作者
Diaz, Javier [1 ]
Martinez, Fernando [1 ,2 ]
Miguel Calderon, Jose [1 ]
Fernandez, Antonio [1 ]
Sauri, Inmaculada [1 ]
Uso, Ruth [1 ]
Luis Trillo, Jose [1 ]
Redon, Josep [1 ,3 ]
Jose Forner, Maria [1 ,2 ]
机构
[1] Univ Valencia, INCLIVA Res Inst, Cardiovasc & Renal Res Grp, Valencia, Spain
[2] Internal Med Hosp Clin Valencia, Valencia, Spain
[3] CIBERObn Carlos III Inst, Madrid, Spain
来源
ESC HEART FAILURE | 2022年 / 9卷 / 06期
关键词
Heart failure; Atrial fibrillation; Hospitalization; Renal function; Stroke; All-cause mortality; CHRONIC KIDNEY-DISEASE; RISK; ASSOCIATIONS; PREDICTORS;
D O I
10.1002/ehf2.14124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The objective of the present study is to assess the bidirectional association between heart failure (HF) and atrial fibrillation (AF) using real-world data. Methods and results From an electronic health recording with a population of 3 799 885 adult subjects, those with prevalent or incident HF were selected and followed throughout a study period of 5 years. Prevalence and incidence of AF, and their impact in the risk for acute HF hospitalization, worsening renal function, ischaemic and haemorrhagic stroke, and all-cause mortality were identified. We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently analysed a subset of patients with incident HF and AF, 57 354 patients (S2). We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently a subset of patients with incident HF and AF, 57 354 patients (S2). The prevalence of AF was 59 906 (46.7%) of the HF patients, while incidence in the 52 was 231/1000 patients/year. In both cohorts, S1 and S2, AF significantly increases the risk of acute heart failure hospitalization [incidence 79.1/1000 and 97.5/1000 patients/year; HR 1.53 (1.48-1.59 95% CI) and HR 1.32 (1.24-1.41 95% CI), respectively], risk of decreased renal function (eGFR reduced by >20%) [66.2/1000 and 94.0/1000 patients/year; HR 1.13 (1.09-1.18 95% CI) and HR 1.22 (1.14-1.31 95% CI), respectively] and all-cause mortality [203/1000 and 294/1000 patients/year; HR 1.62 (1.58-1.65 95% CI) and HR 1.65 (1.59-1.70 95% CI), respectively]. The number of episodes of hospitalization for acute heart failure was also significantly higher in the AF patients (27 623 vs. 10 036, P < 0.001). However, the risk for ischaemic stroke was reduced in the AF subjects [HR 0.66 (0.63-0.74 95% Cl)), probably due to the anticoagulant treatment. Conclusions AF is associated with an increment in the risk of episodes of acute heart failure as well as decline of renal function and increment of all-cause mortality.
引用
收藏
页码:4230 / 4239
页数:10
相关论文
共 50 条
  • [1] Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: A real-world
    Yarmohammadi, Hirad
    Wan, Elaine Y.
    Biviano, Angelo
    Garan, Hasan
    Koehler, Jodi L.
    Stadler, Robert W.
    HEART RHYTHM O2, 2023, 4 (03): : 171 - 179
  • [2] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [3] Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
    Listratov, A. I.
    Ivanov, I. I.
    Ziskina, N. K.
    Efimenko, V. V.
    Zhavoronkova, A. V.
    Miliakova, E. S.
    Kudrjavtseva, A. A.
    Napalkov, D. A.
    Sokolova, A. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (04) : 401 - 408
  • [4] The burden of atrial fibrillation and heart failure in hospitalized patients: A real-world survey in a nationwide snapshot
    Iliodromitis, Konstantinos
    Tzeis, Stylianos
    Xintarakou, Anastasia
    Pyrgakis, Vlasios
    Zari, Ioannis
    Patsilinakos, Sotirios
    Draganigos, Antonios
    Triposkiadis, Filippos
    Hahalis, George
    Karanasios, Athanasios
    Goudevenos, Ioannis
    Michalis, Lampros
    Karvounis, Charalampos
    Parthenakis, Fraggiskos
    Kanakakis, Ioannis
    Tousoulis, Dimitrios
    Iliodromitis, Efstathios
    Vardas, Panos
    HELLENIC JOURNAL OF CARDIOLOGY, 2023, 74 : 18 - 23
  • [5] Edoxaban Anticoagulation in Atrial Fibrillation: Real-World Data and Evidence
    Cay, Serkan
    Kasap, Mithat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (08): : 565 - 573
  • [6] Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
    Yang, Pil-Sung
    Kim, Daehoon
    Sung, Jung-Hoon
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
    Hirai, Toshinori
    Kasai, Hidefumi
    Naganuma, Miyoko
    Hagiwara, Nobuhisa
    Shiga, Tsuyoshi
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01)
  • [8] Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Gupta, Dhiraj
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [9] Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
    Toshinori Hirai
    Hidefumi Kasai
    Miyoko Naganuma
    Nobuhisa Hagiwara
    Tsuyoshi Shiga
    BMC Pharmacology and Toxicology, 23
  • [10] Incidence and prediction of hospitalization for heart failure in patients with atrial fibrillation: the REFLEJA scale
    Llergo, Javier Torres
    Bailen, Magdalena Carrillo
    Aumente, Jose Maria Segura
    Olmo, Maria Rosa Fernandez
    Chiachio, Miguel Puentes
    Guerrero, Juan Carlos Fernandez
    Ortiz, Martin Ruiz
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (09): : 710 - 719